In This Section

NextGen Stars

2022 AACR Annual Meeting NextGen Stars Program

NextGen Star Application DeadlineThursday, September 30, 2021, 5 P.M. ET

The AACR invites Associate Members and early-career Active members to apply to be a NextGen Star and give a talk in a major session at the AACR Annual Meeting 2022. The following rules apply:

Applicants must be AACR Associate Members or Active Members who are not above the level of Assistant Professor or equivalent. Please note that you must be an AACR member in good standing (dues paid for the current year) to submit an application. Applicants who do not meet these criteria will not be able to apply. Nonmembers are encouraged to apply for AACR membership. You may either submit the Official AACR Membership Application online or download the application and submit it to the AACR office with the required documents. Please allow 30 days for application review and approval notification. Visit www.aacr.org/Membership or contact [email protected] with any questions.

Applications consist of an extended abstract (limit 8,000 characters including spaces), a CV, and a letter of recommendation from your P.I., department head, or another mentor who is familiar with your work. Only complete applications will be considered. The application deadline is 5:00 p.m. ET, Thursday, September 30, 2021. No late applications will be considered. All applications must be submitted online through myAACR.

Between 8 and 12 applicants will be chosen to give a talk, regardless of the number of applications received.

Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus 5 minutes for discussion, but the assigned length of the talk may vary depending on the session.

Applicants who are selected to give talks at the Annual Meeting will receive travel support and complimentary registration for the meeting.

The submission of an extended abstract through this application process is completely separate from the submission of a regular abstract for the AACR Annual Meeting. Applicants will be notified of their status by early November. Those who are not selected to give a talk, but still wish to submit an abstract to the Annual Meeting, must submit a separate abstract through the normal abstract submission process by the Thursday, November 18, 2021 deadline.

Congratulations to the 2021 NextGen Stars!

View the abstracts of the NextGen Stars’ presentations from the AACR Annual Meeting 2021:

Andrew Aguirre, MD, PhD

Andrew Aguirre, MD, PhD

Physician and Assistant Professor of Medicine

Harvard Medical School, Boston, Massachusetts

Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in cancers harboring loss of chromosome 18q or 16q

Moran Amit, MD, PhD

Moran Amit, MD, PhD

Assistant Professor, Department of Head and Neck Surgery

The University of Texas MD Anderson Cancer Center, Houston, Texas

Cancer takes a nerve: Loss of p53 drives neuron reprogramming in head and neck cancer

Xuhui Bao, MD, PhD

Xuhui Bao, MD, PhD

Postdoctoral Associate, Department of Dermatology

Duke University Medical Center, Durham, North Carolina

From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy

Shruti Bhatt, PhD

Shruti Bhatt, PhD

Assistant Professor, Department of Pharmacy

National University of Singapore, Singapore

Reduction in mitochondrial priming drives resistance to targeted therapy in acute myeloid leukemia

George M. Burslem, PhD

George M. Burslem, PhD

Assistant Professor, Department of Biochemistry and Biophysics

Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania

Addressing scaffolding roles of oncogenic kinases with targeted protein degradation

Pau Castel, PhD

Pau Castel, PhD

Postdoctoral Scholar, HDF Comprehensive Cancer Center

University of California, San Francisco, San Francisco, California

Oncoprotein duality in cancer and developmental syndromes: Lessons learned from RAS GTPases

Burcu Darst, PhD

Burcu Darst, PhD

Postdoctoral Fellow, Department of Preventive Medicine

Keck School of Medicine of the University of Southern California, Los Angeles, California

Multiethnic prostate cancer GWAS meta-analysis identifies novel variants, improves genetic risk prediction across populations, and informs biological mechanisms of prostate cancer

Christy R. Hagan, PhD

Christy R. Hagan, PhD

Assistant Professor, Department of Biochemistry and Molecular Biology

University of Kansas Medical Center, Kansas City, Kansas

Progesterone-mediated immune evasion in breast cancer

Xin Jin, PhD

Xin Jin, PhD

Scientist/Group Lead

Broad Institute of MIT and Harvard, Cambridge, Massachusetts

A metastasis map of human cancer cell lines

Anusha Kalbasi, MD

Anusha Kalbasi, MD

Assistant Professor, Department of Radiation and Oncology

David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Orthogonal IL-9 receptor signaling reprograms T cells to obviate conditioning chemotherapy before adoptive cell therapy

Yuxuan Phoenix Miao, PhD

Yuxuan Phoenix Miao, PhD

Assistant Professor, Ben May Department of Cancer Research

The University of Chicago, Chicago, Illinois

Decoding the stem cells-immune cell dialogues for cancer immunotherapy

Zeribe Chike Nwosu, PhD

Zeribe Chike Nwosu, PhD

Postdoctoral Research Fellow, Department of Molecular and Integrative Physiology

Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan

Identification of high priority genes for basic and translational pancreatic cancer research

Sara Pedron, PhD

Sara Pedron, PhD

Assistant Professor, Department of Chemical and Biomolecular Engineering

University of Illinois at Urbana-Champaign, Urbana, Illinois

Bioengineered tissue mimetic hydrogels to study brain tumor biology and screen therapeutics

Luis Alberto Perez-Quintero, MD, PhD

Luis Alberto Perez-Quintero, MD, PhD

Postdoctoral Fellow, Department of Biochemistry

Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada

BatF3 commands enhanced anti-tumoral effector functions of CD8 T cells with reduced PTPN1/PTPN2 activity

Debattama Sen, PhD

Debattama Sen, PhD

Member of the Faculty, Center for Cancer Research

Massachusetts General Hospital Cancer Center, Harvard Medical School

Disrupting enhancers within the core epigenetic program of exhaustion improves CD8+ T cell responses and enhances tumor control

Eneda Toska, PhD

Eneda Toska, PhD

Assistant Professor, Department of Oncology

Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland

Epigenetic mechanisms of endocrine therapy response in breast cancer